| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/28/2004 | EP1192273B1 Method for detecting mismatches or mutations in nucleic acid |
| 01/28/2004 | EP1021528B1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 01/28/2004 | EP0974658B1 Probes for the diagnosis of infections caused by streptococcus pyogenes |
| 01/28/2004 | EP0972833B1 Probes for the diagnosis of infections caused by klebsiella pneumoniae |
| 01/28/2004 | EP0968291B1 Antibody fragment-polymer conjugates |
| 01/28/2004 | EP0918790B1 Polycationic sterol derivatives as transfection agents |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0763124B1 Method for introducing nucleic acid in higher eukaryotic cells |
| 01/28/2004 | EP0708829B1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/28/2004 | EP0708637B1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/28/2004 | EP0690675B1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/28/2004 | CN1471588A Method of amplifying nucleic acid |
| 01/28/2004 | CN1471587A Gene markers for lung cancer |
| 01/28/2004 | CN1471585A General means of labeling protein by using wheat embryo cell-free protein synthesis system |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471582A Methods for producing a polypeptide using a consensus translational initiator sequence |
| 01/28/2004 | CN1471581A Human source gene guide sequence, gene carrier and gene expression method |
| 01/28/2004 | CN1471580A Virus Particles with exogenous internal eitopes |
| 01/28/2004 | CN1471579A CRIPTO tumour polypeptide |
| 01/28/2004 | CN1471578A Method of accumulating foreign gene product in plant seed at high level |
| 01/28/2004 | CN1471577A Transgenic plants containing molecular decoys that alter protein content therein |
| 01/28/2004 | CN1471576A Immortalized preosteoblasts and method for their production |
| 01/28/2004 | CN1471575A Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 01/28/2004 | CN1471537A Synthons for oligonucleotide synthesis |
| 01/28/2004 | CN1471408A Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 01/28/2004 | CN1471356A Disease-resistant plants and method of constructing the same |
| 01/28/2004 | CN1470651A Tay of object to be identified composed of at least one DNA fragment |
| 01/28/2004 | CN1470637A Hepatitis B virus core protein mutant and its use |
| 01/28/2004 | CN1470636A Ethylene-insenstiive plant expression vector pBinETR1 and its use |
| 01/28/2004 | CN1470635A Polypeptide-human protein tyrosine phosphatase 10 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470634A Enterpeptidase light chain variant with high activity and high stability |
| 01/28/2004 | CN1470633A Totipotent somatic cell |
| 01/28/2004 | CN1470531A Target gene entraining system using histone as core sequence |
| 01/28/2004 | CN1470530A Humanmachine tumour monoclonal antibody, and its preparing method and use |
| 01/28/2004 | CN1470527A Polypeptide-human calcium ion regulatory secretory action protein 48 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470526A Polypeptide-human muscle BOP protein 41 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470525A Polypeptide-human SEH protein 29 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470524A Polypeptide-human transcriptional elongation factor IIS51 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470523A Polypeptide-zinc finger protein 64 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470522A Polypeptide-XRN-100 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470521A Polypeptide-mitochondrial carrier 12 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470520A Polypeptide-zine finger protein 40 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470295A Electric perforating apparatus capable of expanding electrode interval |
| 01/28/2004 | CN1136316C Gene encoding endoglyco ceramidase |
| 01/28/2004 | CN1136315C Purified polyporus laccases and nucleic acids encoding same |
| 01/28/2004 | CN1136314C Gene for transcription factor capable of altering characters of plants and use thereof |
| 01/28/2004 | CN1136311C Subtilase variants and compositions |
| 01/27/2004 | US6683232 Production of γ linolenic acid by a Δ6-desaturase |
| 01/27/2004 | US6683231 High level production of p-hydroxybenzoic acid in green plants |
| 01/27/2004 | US6683230 Hybrid seed production |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683170 Including peptides which selectively bound by targeted cell so that modified fiber protein is internalized by receptor-mediated endocytosis; trimerization |
| 01/27/2004 | US6683169 Nucleic acid encoding the human peptide histidine transporter 1 and methods of use thereof |
| 01/27/2004 | US6683167 Hybrid oligonucleotide phosphorothioates |
| 01/27/2004 | US6683166 Modified internucleoside linkages (ii) |
| 01/27/2004 | US6683161 Human ependymin |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683159 Purification of antihemophilic factor; obtain antihemophilic mixture, incubate with chromatography column, elute, dilute desorbing solution, recover antihemophilic factor |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683157 Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof |
| 01/27/2004 | US6683155 Purified and isolated polypeptide comprising specified amino acid sequence; regulating degradation of extracellular matrix |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683047 Method of inhibiting transcription utilizing nuclear receptors |
| 01/27/2004 | US6682930 Triplex forming oligonucleotides and their use in anti-HBV |
| 01/27/2004 | US6682929 Adenovector complementing cells |
| 01/27/2004 | US6682928 Cell is transformed to express on its surface a component which binds to an fc receptor of an effector cell used as a vehicle to increase an cell lysis and phagocytosis against an antigen associated with the cell |
| 01/27/2004 | US6682924 Protease variants and compositions |
| 01/27/2004 | US6682922 Polypeptides having phospholipase activity and nucleic acids encoding same |
| 01/27/2004 | US6682920 Compositions and methods for identifying PKB kinase inhibitors |
| 01/27/2004 | US6682919 Polynucleotide sequence encodes the same mature polypeptide, expressed by the fabh gene contained in staphylococcus aureus |
| 01/27/2004 | US6682918 Bacterial sucrose synthase compositions and methods of use |
| 01/27/2004 | US6682917 Rate-limiting enzyme, which converts ribonucleotides to their corresponding deoxyribonucleotides and supplies them for purposes of dna synthesis; drug comprising protein; kit for screening for modulators of protein activity |
| 01/27/2004 | US6682915 Fermentation of enterbacter |
| 01/27/2004 | US6682912 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682908 Mouse growth hormone secretagogue receptor |
| 01/27/2004 | US6682907 Lentivirus have the unique capacity among retroviruses of infecting differentiated non mitotic cells and represent viral candidates of interest for the development of novel vectors |
| 01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
| 01/27/2004 | US6682905 Receptor-type phosphotyrosine phosphatase-alpha |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding |
| 01/27/2004 | US6682894 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 01/27/2004 | US6682891 Methods of identifying nucleic acid sequences encoding plant riboflavin synthase enzymes |
| 01/27/2004 | US6682889 Amplification and detection of organisms of the Chlamydiaceae family |
| 01/27/2004 | US6682887 Snp detection sequences bound to target dna are partially degraded with release of said electrophoretic tag, each released product produced from a given detection sequence has a known, unique electrophoretic mobility |
| 01/27/2004 | US6682885 Method for detecting mutations using an URA3 reporter gene |
| 01/27/2004 | US6682743 Genetically engineered virus for use in the propagation of preferential cells |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | US6682738 Inducing expansion or stress relaxation |
| 01/27/2004 | US6682735 Anti-IgE antibodies |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682730 Transplants for myocardial scars |
| 01/27/2004 | US6682729 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 01/27/2004 | US6682728 Efficient and selective adenoviral-mediated gene transfer into vascular neointima |
| 01/27/2004 | CA2307141C Method and apparatus for making arrays |
| 01/27/2004 | CA2140663C Compounds which inhibit hiv replication |